Markus Zollinger

2.9k citations

30 papers · 2.4k indexed · 1 hit paper · h-index 18

Impact in

Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Hematology top 5%
- Chronic Myeloid Leukemia Treatments

Papers in

Biochemistry 5
- Amino Acid Enzymes and Metabolism 3
Pharmacology 6
- Pharmacogenetics and Drug Metabolism 4

Co-authors: Rainer Albert Volker Brinkmann Robert Hof Eva E. Prieschl Carolyn A. Foster Christian Bruns Michael D. Davis Kevin R. Lynch
Journals: Drug Metabolism and Disposition (9 papers)Journal of Neurochemistry (5 papers)Journal of Medicinal Chemistry (2 papers)Investigational New Drugs (1 paper)European Journal of Biochemistry (1 paper)
Partner nations: Switzerland United States Austria

In The Last Decade

Markus Zollinger

30 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors 2002 · 1.2k citations

Peers

Countries citing papers authored by Markus Zollinger

Since Specialization

Citations

This map shows the geographic impact of Markus Zollinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Zollinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Zollinger more than expected).

Fields of papers citing papers by Markus Zollinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Zollinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Zollinger. The network helps show where Markus Zollinger may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Markus Zollinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Zollinger Line = papers co-authored together Markus Zollinger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Study of the Effect of Cyclosporine on Fevipiprant Pharmacokinetics and its Absolute Bioavailability Using an Intravenous Microdose Approach Drug Metabolism and Disposition ·H. Weiss, Kenichi Umehara, Veit J. Erpenbeck, Yasmin Chauvin Gonçalves de Oliveira, Boris Liebrenz, Amiela Globerson, Markus Zollinger	2020	4
2	Esterase phenotyping in human liverin vitro: specificity of carboxylesterase inhibitors Xenobiotica ·Kenichi Umehara, Markus Zollinger, Elizabeth Kigondu, Reiner Matzker, Enrico Papale, Felix Huth, Hilmar Schiller, Kelly Chibale, Gian Camenisch	2016	18
3	Absorption, distribution, metabolism, and excretion (ADME) of 14C-sonidegib (LDE225) in healthy volunteers Cancer Chemotherapy and Pharmacology ·Markus Zollinger, José Pedro Casado Corzo, Eunju Hurh, 高津英, M Sandhya, Piet Swart	2014	49
4	Metabolism of patupilone in patients with advanced solid tumor malignancies Investigational New Drugs ·Kevin R. Kelly, Markus Zollinger, José Pedro Casado Corzo, Eugene Tan, Alain C. Mita, Felix Waldmeier, Patrick Urban, Margaret Mckenzie, Yanfeng Wang, Piet Swart, Chris H. Takimoto, Monica Mita	2012	2
5	Absorption and Disposition of the Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) in Healthy Volunteers: A Case of Xenobiotic Biotransformation Following Endogenous Metabolic Pathways Drug Metabolism and Disposition ·Markus Zollinger, Hans-Peter Gschwind, Yi Jin, 세진 정, Frédéric J. Zécri, Stefan Hartmann	2010	40
6	CYP4F Enzymes Are Responsible for the Elimination of Fingolimod (FTY720), a Novel Treatment of Relapsing Multiple Sclerosis Drug Metabolism and Disposition ·Yi Jin, Markus Zollinger, Y Brychtová, Alfred Zimmerlin, Christopher Patten	2010	50
7	The Macrolide Everolimus Forms an Unusual Metabolite in Animals and Humans: Identification of a Phosphocholine Ester Drug Metabolism and Disposition ·Markus Zollinger, 세진 정, Andreas Stute, W. Schüler, Richard Sedrani	2008	6
8	Pimecrolimus: Skin disposition after topical administration in minipigs in vivo and in human skin in vitro European Journal of Pharmaceutical Sciences ·Hans-Peter Gschwind, Felix Waldmeier, Markus Zollinger, Alain Schweitzer, Maximilian A. Grassberger	2007	18
9	PIMECROLIMUS: ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION IN HEALTHY VOLUNTEERS AFTER A SINGLE ORAL DOSE AND SUPPLEMENTARY INVESTIGATIONS IN VITRO Drug Metabolism and Disposition ·Markus Zollinger, Felix Waldmeier, Stefan Hartmann, Gerhard Zenke, Alfred Zimmerlin, Ulrike Glaenzel, Eric J. HallD.Sc, Alain Schweitzer, 聡菅沼, 闻生, Maximilian A. Grassberger	2006	11
10	A microplate solid scintillation counter as a radioactivity detector for high performance liquid chromatography in drug metabolism: Validation and applications Journal of Chromatography A ·Gerard Bruin, Felix Waldmeier, K. Olaf Boernsen, Ulrike Pfaar, Gerhard Groß, Markus Zollinger	2006	25
11	METABOLISM AND DISPOSITION OF IMATINIB MESYLATE IN HEALTHY VOLUNTEERS Drug Metabolism and Disposition ·Hans-Peter Gschwind, Ulrike Pfaar, Felix Waldmeier, Markus Zollinger, 세진 정, Peter Zbinden, Michael Hayes, Rolf Pokorny, Michael Seiberling, Monique Ben‐Am, Bin Peng, Gerhard Groß	2005	186
12	The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors Journal of Biological Chemistry ·Volker Brinkmann, Michael D. Davis, Christopher E. Heise, Rainer Albert, Sylvain Cottens, Robert Hof, Christian Bruns, Eva E. Prieschl, Thomas Baumruker, Peter Hiestand, Carolyn A. Foster, Markus Zollinger, Kevin R. Lynch Hit paper breakdown →	2002	1246
13	Multiple Cytochrome P-450s Involved in the Metabolism of Terbinafine Suggest a Limited Potential for Drug-Drug Interactions Drug Metabolism and Disposition ·Alison E.M. Vickers, John Sinclair, Markus Zollinger, Francis Heitz, Noémi Thinat, T. Verkoyen, Volker Fischer	1999	82
14	S‐Nitrosoglutathione in Rat Cerebellum: Identification and Quantification by Liquid Chromatography‐Mass Spectrometry Journal of Neurochemistry ·Т Б Лысунец, Ursula Gutteck‐Amsler, Markus Zollinger, Kim Q.	1997	153
15	γ‐Glutamylglutamine and Taurine Concentrations Are Decreased in the Cerebrospinal Fluid of Drug‐Naive Patients with Schizophrenic Disorders Journal of Neurochemistry ·Kim Q., Christoph Lauer, Wolfgang Schreiber, Markus Zollinger, Ursula Gutteck‐Amsler, Michel Cuénod, (unknown)	1995	67
16	Release of N‐Acetylaspartylglutamate from Slices of Rat Cerebellum, Striatum, and Spinal Cord, and the Effect of Climbing Fiber Deprivation Journal of Neurochemistry ·Markus Zollinger, M. Escobar, Ursula Gutteck‐Amsler, Kim Q., P. Streit, Michel Cuénod	1994	30
17	The biotransformation of the ergot derivative CQA 206-291 in human, dog, and rat liver slice cultures and prediction of in vivo plasma clearance. Drug Metabolism and Disposition ·Alison E.M. Vickers, Giuseppe Caruso, Markus Zollinger, K. Kuchitsu, Amparo Larrauri, Choong K. Oh, Klaus Brendel	1993	27
18	Alkylacyl glycerophosphoinositol in human and bovine erythrocytes European Journal of Biochemistry ·Peter Bütikofer, Markus Zollinger, Urs Brodbeck	1992	14
19	Cysteine: Depolarization‐Induced Release from Rat Brain In Vitro Journal of Neurochemistry ·雷军军, Kim Q., Markus Zollinger, Kaspar H. Winterhalter, Michel Cuénod	1989	25
20	Release of N‐Acetylaspartylglutamate on Depolarization of Rat Brain Slices Journal of Neurochemistry ·Markus Zollinger, Munmun De, Kim Q., P. Streit, Michel Cuénod	1988	61

About Markus Zollinger

Markus Zollinger is a scholar working on Biochemistry, Pharmacology, Transplantation, Spectroscopy and Cellular and Molecular Neuroscience, having authored 30 papers that have together received 2.4k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (5 papers), Analytical Chemistry and Chromatography (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Mass Spectrometry Techniques and Applications (4 papers), Sphingolipid Metabolism and Signaling (4 papers), Amino Acid Enzymes and Metabolism (3 papers), Plant and fungal interactions (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Pharmacology (200 citations), Hematology (255 citations), Molecular Biology (1.5k citations), Neurology (174 citations) and Biochemistry (149 citations). Markus Zollinger has collaborated with scholars based in Switzerland, United States and Austria. Frequent co-authors include Rainer Albert, Volker Brinkmann, Robert Hof, Eva E. Prieschl, Carolyn A. Foster, Christian Bruns, Michael D. Davis, Kevin R. Lynch, Christopher E. Heise and Thomas Baumruker. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Neurochemistry, Journal of Medicinal Chemistry, Investigational New Drugs and European Journal of Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact